Our identity, heritage, and market presence
Parami Partners is a healthcare-focused private equity firm that acquires, builds and transforms regulated businesses across vaccines, biologics, sterile injectables and medical devices. We combine disciplined investing, clear strategic direction and embedded operating leadership to create sustainable long-term value.
Our firm draws on deep knowledge on operating and investing in multiple pharmaceutical, vaccine and medical device businesses
Clear long-term investment strategy and disciplined value-creation roadmaps throughout ownership
Sterile manufacturing for regulated market formularies
Integrated R&D and manufacturing across vaccines, biologics and sterile injectables for regulated and global health markets
ISO 13485 manufacturing, vascular access and critical-care devices, indigenous supply chains
Our experience spans global regulated markets, with a track record of scaling manufacturing platforms, executing acquisitions, and driving operational excellence.
